Ingalls & Snyder LLC’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-10,715
Closed -$20K 449
2025
Q1
$20K Sell
10,715
-3,335
-24% -$6.23K ﹤0.01% 433
2024
Q4
$52K Sell
14,050
-11,602
-45% -$42.9K ﹤0.01% 415
2024
Q3
$82K Sell
25,652
-6,812
-21% -$21.8K ﹤0.01% 421
2024
Q2
$267K Buy
32,464
+16,708
+106% +$137K 0.01% 343
2024
Q1
$228K Sell
15,756
-494
-3% -$7.15K 0.01% 378
2023
Q4
$150K Sell
16,250
-580
-3% -$5.35K 0.01% 398
2023
Q3
$278K Sell
16,830
-50
-0.3% -$826 0.01% 340
2023
Q2
$107K Sell
16,880
-131
-0.8% -$830 0.01% 398
2023
Q1
$58K Sell
17,011
-3,745
-18% -$12.8K ﹤0.01% 400
2022
Q4
$120K Sell
20,756
-1,225
-6% -$7.08K 0.01% 394
2022
Q3
$207K Sell
21,981
-1,456
-6% -$13.7K 0.01% 371
2022
Q2
$523K Sell
23,437
-110
-0.5% -$2.46K 0.03% 262
2022
Q1
$1.3M Buy
23,547
+16,165
+219% +$889K 0.06% 186
2021
Q4
$488K Buy
7,382
+1,477
+25% +$97.6K 0.02% 294
2021
Q3
$496K Buy
+5,905
New +$496K 0.02% 292